
MDLZ · NASDAQ-GS
Expected to report Feb 2, 2027 — estimated from last year’s reporting date.
Consensus is $0.88 EPS for Dec 2026 across 7 estimates, ranging $0.85 to $0.93.
Mondelēz delivered a modestly growing sales quarter with better underlying profitability, while headline GAAP earnings were amplified by volatile derivative accounting. Revenue of $9.97 billion increased 2.3% year over year, and organic revenue grew 2.1%, led by 1.8 points of volume/mix and 0.3 points of pricing. Adjusted EPS of $0.78 exceeded the supplied $0.72 consensus by 8.3% and rose 5.5% at constant currency. GAAP diluted EPS of $1.02 was up 78.9% from $0.57 a year earlier, largely reflecting a favorable derivative mark-to-market comparison and other items excluded from adjusted results.
Constant-currency adjusted operating income rose 17.0% to $1.37 billion and its margin expanded 190 basis points to 13.9%, as lower raw-material and manufacturing costs, pricing and volume/mix outweighed higher SG&A and brand support spending. The quarter’s improvement follows a weaker year-to-date underlying picture: adjusted EPS was down 4.1% at constant currency through September. Sequentially, revenue rose from $9.36 billion in Q2, but GAAP operating income and EPS fell from $1.95 billion and $1.20. Management reaffirmed its 2026 outlook: at least 2% organic revenue growth, flat-to-5% constant-currency adjusted EPS growth and approximately $3 billion of free cash flow, against continued geopolitical, trade and commodity uncertainty.